Federal Practitioner

How does SARS-CoV-2 affect other respiratory diseases?

January 24, 2023

‘Very doable’ low-dose workout enough to treat knee OA

January 24, 2023

Pain

Depression guidelines fall short in characterizing withdrawal

January 24, 2023

Depression and schizophrenia: Many biological and clinical similarities

January 24, 2023

Depression

Mastocytosis: Rare, underdiagnosed, potentially fatal

January 24, 2023

PCSK9 inhibitors for severe COVID? Pilot trial signals of benefit

January 24, 2023

COVID-19 Updates

Guidelines recommend CBT alone for mild acute depression, more options for more severe cases

January 23, 2023

FDA approves new type 2 diabetes drug bexagliflozin

January 23, 2023

Diabetes

Adding venetoclax improves ibrutinib outcomes in CLL

January 23, 2023

People with cancer should be wary of taking dietary supplements

January 23, 2023

Doctors’ happiness has not rebounded as pandemic drags on

January 23, 2023

Tucatinib plus trastuzumab approved for HER2+ colorectal cancer

January 23, 2023

Oncology

Mpox: Dermatology registry data pinpoints unique signs

January 23, 2023

U.S. ketamine poisonings up 81%

January 20, 2023

Two short-term exposure therapies linked to PTSD reductions

January 20, 2023